China Posts Weak Data, Sony CEO Steps Down

March 10 (Bloomberg) -- On today's "First Up," Bloomberg News takes a first look at the stocks and stories making headlines. (Source: Bloomberg)
Mylan Board Rejects $40.1B Teva Takeover Bid
11:50 - Mylan NV’s board unanimously rejected a $40.1 billion takeover offer from Teva Pharmaceutical Industries Ltd., saying it’s too low and doesn’t address the difficulties of combining companies with different cultures. Bloomberg’s Scarlet Fu reports on “In The Loop.” (Source: Bloomberg)
  • Apple’s iPhone May Reach New Sales Peak in China
  • Why Investors Are Skeptical Over Deutsche Bank Overhaul
  • Hopes for Finding Nepal Survivors Fade